Carregant...

Efficacy of Neulasta(®) or Neupogen(®) on H- and GI-ARS mortality and hematopoietic recovery in nonhuman primates after 10 Gy irradiation with 2.5% bone marrow sparing

A nonhuman primate (NHP) model of acute, partial-body, high dose, irradiation with minimal (2.5%) bone marrow sparing (PBI/BM2.5) was used to assess the endogenous gastrointestinal and hematopoietic recovery and the ability of Neulasta(®) (pegylated granulocyte colony stimulating factor [G-CSF]) or...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Health Phys
Autors principals: Farese, Ann M., Bennett, Alexander W., Gibbs, Allison M., Hankey, Kim G., Prado, Karl, Jackson, William, MacVittie, Thomas J.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6349470/
https://ncbi.nlm.nih.gov/pubmed/30281533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HP.0000000000000878
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!